Insiders Insmed Incorporated

Equities

Delayed Nasdaq Other stock markets 03:50:11 2024-04-29 pm EDT			5-day change	1st Jan Change
25.02 ^USD	+0.89%		+3.65%	-19.36%

Apr. 23	Truist Starts Insmed at Buy With $48 Price Target, Sees Multi-Billion-Dollar Opportunities in Respiratory, Inflammatory Diseases	MT
Apr. 11	Barclays Adjusts Price Target on Insmed to $40 From $37, Maintains Overweight Rating	MT

Insmed Insider Sold Shares Worth $620,089, According to a Recent SEC Filing	Jan. 05	MT
Insmed Insider Sold Shares Worth $395,970, According to a Recent SEC Filing	Dec. 22	MT
Insmed Insider Sold Shares Worth $2,696,449, According to a Recent SEC Filing	23-10-31	MT
Insider Sell: Insmed	23-06-15	MT
Insider Sell: Insmed	23-05-17	MT
Insider Buy: Insmed	23-05-17	MT
Insider Sell: Insmed	23-05-17	MT
Insider Sell: Insmed	23-01-12	MT
Insider Sell: Insmed	22-11-22	MT
Insider Buy: Insmed	22-11-02	MT
Insider Buy: Insmed	22-11-02	MT
Insider Sell: Insmed	22-08-11	MT
Insmed Incorporated Names Drayton Wise as Chief Commercial Officer	22-05-23	CI
Insider Sell: Insmed	22-05-18	MT
Insider Sell: Insmed	22-03-28	MT
Insider Sell: Insmed	21-12-29	MT
Insider Sell: Insmed	21-11-03	MT
Insider Buy: Insmed	21-11-03	MT
Insider Buy: Insmed	21-11-03	MT
Insider Sell: Insmed	21-10-01	MT

No results for this search